Portfolio Holdings Detail for ISIN GB0001990497
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63

Stock Name / Fund	City Of London Investment Trust
Issuer
Common Stock Ticker	CTY(GBX) LSE
Common Stock Ticker	CLN(EUR) F
Common Stock Ticker	CTY.LS(GBX) CXE
Common Stock Ticker	CTY.L(GBP) LSE

Holdings detail for GSK

Show aggregate GSK holdings

News associated with GSK

Brokerages Set GSK PLC Sponsored ADR (NYSE:GSK) Target Price at $37.38

GSK PLC Sponsored ADR (NYSE:GSK – Get Free Report) has been assigned an average rating of “Hold” from the ten research firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has issued a strong buy […] - 2025-07-04 05:22:52

Stock Traders Buy Large Volume of Put Options on GSK (NYSE:GSK)

GSK PLC Sponsored ADR (NYSE:GSK – Get Free Report) was the target of unusually large options trading on Tuesday. Stock traders purchased 14,938 put options on the stock. This represents an increase of approximately 133% compared to the typical daily volume of 6,411 put options. GSK Stock Performance Shares of GSK stock opened at $38.52 […] - 2025-07-03 05:13:03

Diversified Trust Co Takes Position in GSK PLC Sponsored ADR (NYSE:GSK)

Diversified Trust Co purchased a new stake in GSK PLC Sponsored ADR (NYSE:GSK – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 9,644 shares of the pharmaceutical company’s stock, valued at approximately $374,000. Several other institutional investors and hedge funds […] - 2025-07-01 09:38:52

GSK (LON:GSK) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

GSK plc (LON:GSK – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,415.92 ($19.44) and traded as low as GBX 1,385 ($19.02). GSK shares last traded at GBX 1,390 ($19.09), with a volume of […] - 2025-07-01 07:21:05

Wednesday's ETF Movers: RSSL, RODM

In trading on Wednesday, the Global X Russell 2000 ETF is outperforming other ETFs, up about 1.4% on the day. Components of that ETF showing particular strength include shares of Nektar Therapeutics, up about 35.8% and shares of Aerovironment, up about 23.1% on the day. And un - 2025-06-25 16:21:40

PFG Investments LLC Cuts Holdings in GSK PLC Sponsored ADR (NYSE:GSK)

PFG Investments LLC trimmed its holdings in shares of GSK PLC Sponsored ADR (NYSE:GSK – Free Report) by 3.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 10,035 shares of the pharmaceutical company’s stock after selling 411 shares during the quarter. PFG Investments LLC’s holdings in GSK were worth $389,000 as of its […] - 2025-06-25 08:18:58

Wendy Becker Acquires 545 Shares of GSK plc (LON:GSK) Stock

GSK plc (LON:GSK – Get Free Report) insider Wendy Becker bought 545 shares of the firm’s stock in a transaction that occurred on Friday, June 20th. The shares were acquired at an average cost of GBX 1,435 ($19.53) per share, for a total transaction of £7,820.75 ($10,646.27). GSK Trading Up 0.5% Shares of LON:GSK opened […] - 2025-06-25 05:56:43

GSK PLC Sponsored ADR (NYSE:GSK) Shares Sold by Blue Trust Inc.

Blue Trust Inc. reduced its position in GSK PLC Sponsored ADR (NYSE:GSK – Free Report) by 5.5% in the 1st quarter, Holdings Channel.com reports. The fund owned 5,642 shares of the pharmaceutical company’s stock after selling 328 shares during the quarter. Blue Trust Inc.’s holdings in GSK were worth $219,000 as of its most recent […] - 2025-06-24 08:02:59

GSK plc (LON:GSK) Insider Acquires £19,372.50 in Stock

GSK plc (LON:GSK – Get Free Report) insider Jonathan Symonds bought 1,350 shares of the company’s stock in a transaction on Friday, June 20th. The shares were acquired at an average price of GBX 1,435 ($19.43) per share, with a total value of £19,372.50 ($26,228.68). GSK Stock Performance Shares of LON:GSK opened at GBX 1,403 […] - 2025-06-24 05:26:48

GSK PLC Sponsored ADR (NYSE:GSK) Shares Acquired by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lifted its stake in shares of GSK PLC Sponsored ADR (NYSE:GSK – Free Report) by 4.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 305,395 shares of the pharmaceutical company’s stock after buying an additional 13,239 shares […] - 2025-06-20 11:06:48

GSK: Japan's Ministry Of Health To Review Application For Use Of RSV Vaccine In Adults Aged 18-49

(RTTNews) - GSK plc (GSK, GSK.L) announced that Japan's Ministry of Health, Labour and Welfare has accepted the company's application to expand the use of adjuvanted recombinant respiratory syncytial virus vaccine to include adults aged 18-49 at increased risk of severe RSV disea - 2025-06-20 06:20:52

Farther Finance Advisors LLC Purchases 2,030 Shares of GSK PLC Sponsored ADR (NYSE:GSK)

Farther Finance Advisors LLC lifted its position in GSK PLC Sponsored ADR (NYSE:GSK – Free Report) by 50.1% in the first quarter, Holdings Channel.com reports. The institutional investor owned 6,085 shares of the pharmaceutical company’s stock after buying an additional 2,030 shares during the period. Farther Finance Advisors LLC’s holdings in GSK were worth $230,000 […] - 2025-06-19 07:26:59

CX Institutional Takes Position in GSK PLC Sponsored ADR (NYSE:GSK)

CX Institutional purchased a new stake in GSK PLC Sponsored ADR (NYSE:GSK – Free Report) in the first quarter, HoldingsChannel reports. The fund purchased 1,175 shares of the pharmaceutical company’s stock, valued at approximately $46,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in GSK. Integrated Advisors Network […] - 2025-06-18 07:46:59

Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Franco-Nevada (FNV) and Fortuna Mining (FSM) have performed compared to their sector so far this year. - 2025-06-16 13:40:06

Is Central Japan Railway Co. (CJPRY) Stock Outpacing Its Transportation Peers This Year?

Here is how Central Japan Railway Co. (CJPRY) and Copa Holdings (CPA) have performed compared to their sector so far this year. - 2025-06-16 13:40:06

Is EPR Properties (EPR) Stock Outpacing Its Finance Peers This Year?

Here is how EPR Properties (EPR) and Aviva (AVVIY) have performed compared to their sector so far this year. - 2025-06-16 13:40:05

Is Adyen (ADYEY) Stock Outpacing Its Computer and Technology Peers This Year?

Here is how Adyen N.V. Unsponsored ADR (ADYEY) and Intuit (INTU) have performed compared to their sector so far this year. - 2025-06-16 13:40:05

GSK plc (LON:GSK) Receives GBX 1,862.50 Average PT from Brokerages

GSK plc (LON:GSK – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 1 year price objective […] - 2025-06-16 07:11:04

Nuveen Asset Management LLC Cuts Holdings in GSK plc (NYSE:GSK)

Nuveen Asset Management LLC trimmed its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 14.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 42,293 shares of the pharmaceutical company’s stock after selling 7,310 shares during the period. Nuveen […] - 2025-06-04 07:36:53

GSK To Buy Back Up To GBP 0.45 Bln Shares In Second Tranche Of GBP 2 Bln Programme

(RTTNews) - British drugmaker GSK plc (GSK, GSK.L) announced Wednesday the commencement of the second tranche of its previously announced 2 billion pounds share buyback programme, to buy up to 0.45 billion pounds in shares. - 2025-06-04 06:16:25

Wealth Enhancement Advisory Services LLC Purchases 13,039 Shares of GSK plc (NYSE:GSK)

Wealth Enhancement Advisory Services LLC grew its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 8.1% in the fourth quarter, HoldingsChannel reports. The fund owned 174,688 shares of the pharmaceutical company’s stock after purchasing an additional 13,039 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in GSK were worth $5,908,000 […] - 2025-06-03 08:37:03

Deutsche Bank AG Lowers Position in GSK plc (NYSE:GSK)

Deutsche Bank AG trimmed its stake in GSK plc (NYSE:GSK – Free Report) by 99.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 7,676 shares of the pharmaceutical company’s stock after selling 742,739 shares during the quarter. Deutsche Bank AG’s holdings in GSK were worth $260,000 at the end of the most recent […] - 2025-06-02 07:42:58

GSK Plc: FDA Accepts Linerixibat NDA For Review

(RTTNews) - GSK plc (GSK) announced the FDA has accepted for review the NDA for linerixibat, an investigational targeted inhibitor of the ileal bile acid transporter, for the treatment of cholestatic pruritus in patients with primary biliary cholangitis. The PDUFA goal date is 24 - 2025-06-02 06:24:31

Biotech Stocks Facing FDA Decision In June 2025

(RTTNews) - As May draws to a close, it's time to turn our attention to the FDA's upcoming slate of decisions. From January through May 2025, the U.S. regulatory agency has approved 13 novel drugs, a modest decline from the 16 approvals recorded during the same period in 2024. - 2025-05-30 09:02:12

Tidal Investments LLC Raises Stock Position in GSK plc (NYSE:GSK)

Tidal Investments LLC boosted its holdings in GSK plc (NYSE:GSK – Free Report) by 6.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 31,015 shares of the pharmaceutical company’s stock after buying an additional 1,823 shares during the period. Tidal Investments LLC’s holdings in GSK were […] - 2025-05-26 08:40:57

D. E. Shaw & Co. Inc. Has $3.86 Million Stock Position in GSK plc (NYSE:GSK)

D. E. Shaw & Co. Inc. cut its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 7.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 114,110 shares of the pharmaceutical company’s stock after selling 8,746 shares during the quarter. D. E. […] - 2025-05-19 07:55:01

GSK: Japan Approves Blenrep Combinations To Treat Relapsed/refractory Multiple Myeloma In Adults

(RTTNews) - British drug maker GSK plc (GSK.L, GSK) announced Monday the approval of Blenrep combinations by Japan's Ministry of Health, Labour and Welfare or MHLW for the treatment of adults with relapsed or refractory multiple myeloma. - 2025-05-19 06:31:33

Julie Brown Purchases 10 Shares of GSK plc (LON:GSK) Stock

GSK plc (LON:GSK – Get Free Report) insider Julie Brown purchased 10 shares of the stock in a transaction dated Monday, May 12th. The shares were purchased at an average price of GBX 1,351 ($17.92) per share, with a total value of £135.10 ($179.23). GSK Trading Up 0.1% Shares of GSK stock opened at GBX […] - 2025-05-15 05:15:06

Invesco Ltd. Decreases Position in GSK plc (NYSE:GSK)

Invesco Ltd. trimmed its position in GSK plc (NYSE:GSK – Free Report) by 67.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,606 shares of the pharmaceutical company’s stock after selling 15,460 shares during the quarter. Invesco Ltd.’s holdings in GSK were worth $257,000 at the end of the most recent reporting period. […] - 2025-05-05 07:26:47

GSK plc (LON:GSK) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of GSK plc (LON:GSK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy […] - 2025-04-24 07:18:58

City Of London Investment Trust GSK holdings

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GSK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer